Quest Diagnostics shares are trading lower. The company reported Q2 financial results.
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics shares are trading lower following the release of their Q2 financial results.
July 23, 2024 | 3:14 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Quest Diagnostics shares are trading lower after the company reported its Q2 financial results.
The decline in Quest Diagnostics' share price is directly linked to the market's reaction to their Q2 financial results. Investors likely found the results disappointing, leading to a sell-off.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100